• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本心脏植入式电子设备感染与移位的发生率:来自129家机构的调查结果。

Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey.

作者信息

Nakajima Hiroshi, Taki Masami

机构信息

Japan Research Institute for Device Therapy, NT Bldg., 1-1-12, Yushima, Bunkyo-ku, Tokyo 113-0034, Japan.

Medtronic Japan Co., Ltd., 2-14-1 Higashi Shimbashi, Minato-ku, Tokyo 105-0021 Japan.

出版信息

J Arrhythm. 2016 Aug;32(4):303-7. doi: 10.1016/j.joa.2015.09.006. Epub 2015 Nov 4.

DOI:10.1016/j.joa.2015.09.006
PMID:27588154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4996866/
Abstract

BACKGROUND

We conducted a survey of the infection burden associated with the implantation of cardiac implantable electronic devices (CIEDs) in Japan.

METHODS

The institutes were selected using annual device implantation data provided by Medtronic Japan Co., Ltd. The data sampling period was from January 1 to December 31, 2013. Institutes were classified into Group P, at which only pacemakers were implanted, and Group A, at which other CIEDs were implanted. Group P was further classified into three sub-groups by implantation number. The infection rate was compared between groups using logistic regression analysis.

RESULTS

A total of 129 of 138 institutes responded. The annual infection rate was 1.12% for overall CIEDs. The institute at which 15-29 pacemakers were implanted had a high infection rate (2.11%). No statistically significant difference was observed (adjusted p=0.1131). The overall migration rate was 0.50%. Complete removal of the CIED system was performed in 55.8% of patients who underwent implantation.

CONCLUSIONS

This survey was the first on CIED infection and migration in Japan. The CIED infection rate (1.12%) was similar to that previously reported. A high infection rate (2.77%) was observed in the infection experienced institutes.

摘要

背景

我们对日本心脏植入式电子设备(CIED)植入相关的感染负担进行了一项调查。

方法

利用美敦力日本有限公司提供的年度设备植入数据选择研究机构。数据采样期为2013年1月1日至12月31日。研究机构被分为仅植入起搏器的P组和植入其他CIED的A组。P组根据植入数量进一步分为三个亚组。使用逻辑回归分析比较各组之间的感染率。

结果

138个研究机构中共有129个做出了回应。CIED总体的年感染率为1.12%。植入15 - 29个起搏器的机构感染率较高(2.11%)。未观察到统计学上的显著差异(校正p = 0.1131)。总体迁移率为0.50%。在接受植入的患者中,55.8%的患者进行了CIED系统的完全移除。

结论

这项调查是日本首次关于CIED感染和迁移的调查。CIED感染率(1.12%)与先前报道的相似。在有感染经历的机构中观察到较高的感染率(2.77%)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a887/4996866/95a02a924fdc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a887/4996866/442230717530/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a887/4996866/95a02a924fdc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a887/4996866/442230717530/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a887/4996866/95a02a924fdc/gr2.jpg

相似文献

1
Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey.日本心脏植入式电子设备感染与移位的发生率:来自129家机构的调查结果。
J Arrhythm. 2016 Aug;32(4):303-7. doi: 10.1016/j.joa.2015.09.006. Epub 2015 Nov 4.
2
In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.心脏植入式电子设备植入后的院内并发症:日本全国住院患者数据库分析
J Cardiol. 2017 Nov;70(5):405-410. doi: 10.1016/j.jjcc.2017.02.013. Epub 2017 Apr 20.
3
The Burden and Risk Factors for Infection of Transvenous Cardiovascular Implantable Electronic Device: a Nationwide Cohort Study.经静脉植入式心血管电子装置感染的负担及危险因素:一项全国性队列研究
Korean Circ J. 2019 Aug;49(8):742-752. doi: 10.4070/kcj.2018.0361. Epub 2019 Apr 8.
4
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.接受抗菌心血管植入式电子设备包膜患者的风险概况和结局:一项回顾性分析。
World J Cardiol. 2022 Mar 26;14(3):177-186. doi: 10.4330/wjc.v14.i3.177.
5
Re-implantation after extraction of a cardiac implantable electronic device.心脏植入式电子设备取出后的再植入。
Acta Cardiol. 2020 Oct;75(6):505-513. doi: 10.1080/00015385.2019.1620997. Epub 2019 May 30.
6
Infection and migration incidence of cardiac implantable electrical devices in Japan: Web-based survey results.日本心脏植入式电子装置的感染与迁移发生率:基于网络的调查结果。
J Arrhythm. 2020 Apr 21;36(4):780-783. doi: 10.1002/joa3.12345. eCollection 2020 Aug.
7
Safety and Efficacy of Submuscular Implantation With Resterilized Cardiac Implantable Electronic Device in Patients With Device Infection: A Retrospective Observational Study in Taiwan.重新消毒的心脏植入式电子设备肌下植入治疗设备感染患者的安全性和有效性:台湾一项回顾性观察研究
Open Forum Infect Dis. 2022 Apr 10;9(5):ofac100. doi: 10.1093/ofid/ofac100. eCollection 2022 May.
8
Increased long-term mortality in patients with cardiovascular implantable electronic device infections.心血管植入式电子设备感染患者的长期死亡率增加。
Pacing Clin Electrophysiol. 2015 Feb;38(2):231-9. doi: 10.1111/pace.12518. Epub 2014 Sep 21.
9
Cardiac Implantable Electronic Device Infection in Patients at Risk.高危患者的心脏植入式电子设备感染
Arrhythm Electrophysiol Rev. 2016 May;5(1):65-71. doi: 10.15420/aer.2015.27.2.
10
Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.心脏植入式电子设备 (CIED) 感染费用高昂,并与住院时间延长有关:英国回顾性观察研究。
PLoS One. 2019 Jan 2;14(1):e0206611. doi: 10.1371/journal.pone.0206611. eCollection 2019.

引用本文的文献

1
Editorial to "Infection and migration incidence of Cardiac Implantable Electrical Devices in Japan: Web-based survey results".《日本心脏植入式电子装置的感染与迁移发生率:基于网络的调查结果》的社论
J Arrhythm. 2020 May 29;36(4):784. doi: 10.1002/joa3.12352. eCollection 2020 Aug.
2
Infection and migration incidence of cardiac implantable electrical devices in Japan: Web-based survey results.日本心脏植入式电子装置的感染与迁移发生率:基于网络的调查结果。
J Arrhythm. 2020 Apr 21;36(4):780-783. doi: 10.1002/joa3.12345. eCollection 2020 Aug.
3
Cardiac implantable electronic device infection in the cardiac referral center in Thailand: incidence, microbiology, risk factors, and outcomes.

本文引用的文献

1
Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.心脏植入式电子设备感染:发生率、风险因素以及 AigisRx 抗菌封套的效果。
Heart Rhythm. 2014 Apr;11(4):595-601. doi: 10.1016/j.hrthm.2013.12.013. Epub 2013 Dec 10.
2
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.如何在欧洲中心诊断、治疗和预防 CIED 感染:欧洲心律协会调查结果。
Europace. 2012 Nov;14(11):1666-9. doi: 10.1093/europace/eus350.
3
16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.
泰国心脏转诊中心的心脏植入式电子设备感染:发病率、微生物学、危险因素及结局
J Arrhythm. 2018 Sep 27;34(6):632-639. doi: 10.1002/joa3.12123. eCollection 2018 Dec.
4
Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum.皮下植入式心律转复除颤器在一名患有漏斗胸的日本患者体内成功进行肌间植入。
J Arrhythm. 2017 Feb;33(1):63-65. doi: 10.1016/j.joa.2016.04.005. Epub 2016 Jun 1.
1993 年至 2008 年美国起搏器和植入式心脏复律除颤器感染负担的 16 年趋势。
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6. doi: 10.1016/j.jacc.2011.04.033.
4
Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006.美国起搏器和植入式心脏复律除颤器的植入趋势及患者概况:1993 - 2006年
Pacing Clin Electrophysiol. 2010 Jun 1;33(6):705-11. doi: 10.1111/j.1540-8159.2009.02670.x. Epub 2010 Jan 4.
5
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.心血管植入式电子设备感染及其管理的最新进展:美国心脏协会的科学声明。
Circulation. 2010 Jan 26;121(3):458-77. doi: 10.1161/CIRCULATIONAHA.109.192665. Epub 2010 Jan 4.
6
Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.心脏再同步治疗装置感染的流行情况及相关危险因素。
Eur Heart J. 2010 Jan;31(2):203-10. doi: 10.1093/eurheartj/ehp421. Epub 2009 Oct 28.
7
Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.起搏器和心脏复律除颤器植入前抗生素预防的疗效:一项大型、前瞻性、随机、双盲、安慰剂对照试验的结果
Circ Arrhythm Electrophysiol. 2009 Feb;2(1):29-34. doi: 10.1161/CIRCEP.108.795906. Epub 2009 Feb 10.
8
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).经静脉导线拔除:心律学会关于设施、培训、适应症及患者管理的专家共识:本文件获美国心脏协会(AHA)认可。
Heart Rhythm. 2009 Jul;6(7):1085-104. doi: 10.1016/j.hrthm.2009.05.020. Epub 2009 May 22.
9
Risk factors and time delay associated with cardiac device infections: Leiden device registry.与心脏设备感染相关的危险因素和时间延迟:莱顿设备登记处
Heart. 2009 May;95(9):715-20. doi: 10.1136/hrt.2008.151985. Epub 2008 Nov 26.
10
The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project.心脏起搏与心脏复律除颤器全球调查:2005历年 一项国际心脏起搏与电生理学会(ICPES)项目
Pacing Clin Electrophysiol. 2008 Sep;31(9):1202-12. doi: 10.1111/j.1540-8159.2008.01164.x.